Compare JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) vs Eli Lilly And Co (LLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JPMorgan Nasdaq Equity Premium Income ETF vs Eli Lilly And Co — how do they compare? JPMorgan Nasdaq Equity Premium Income ETF trades at $59.67, while Eli Lilly And Co trades at $1,170.93 (market cap $1.02T). The key difference: Eli Lilly And Co pays a 0.6% dividend while JPMorgan Nasdaq Equity Premium Income ETF pays none. Which is the better fit depends on your goals.
| JEPQ | LLY | |
|---|---|---|
Sector | Income / Options Overlay | Health |
52-Week High | $61.46 | $1.24K |
52-Week Low | $53.77 | $625.65 |
Market Cap | — | $1.02T |
Enterprise Value | — | $1.06T |
Dividend Yield | — | 0.6% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About JPMorgan Nasdaq Equity Premium Income ETF
JEPQ seeks to provide monthly income and exposure to the Nasdaq-100 Index with less volatility. It uses a methodology that combines high-growth tech stocks with an options strategy to capture income.
Read more on JEPQ →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
